D.A. DAVIDSON & CO. - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 56 filers reported holding ANTHERA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 2.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$43,000
-41.1%
101,150
-10.3%
0.00%
-50.0%
Q4 2016$73,000
-92.7%
112,780
-64.5%
0.00%
-92.0%
Q3 2016$1,000,000
+423.6%
317,700
+412.8%
0.02%
+316.7%
Q2 2016$191,000
-14.0%
61,950
+1.0%
0.01%
-14.3%
Q1 2016$222,000
+1133.3%
61,350
+1945.0%
0.01%
+600.0%
Q3 2015$18,000
-58.1%
3,000
-40.0%
0.00%0.0%
Q2 2015$43,000
+258.3%
5,000
+72.4%
0.00%
Q1 2015$12,0002,9000.00%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,250,000$1,975,0001.00%
Broadfin Capital, LLC 3,567,624$5,636,0000.24%
Abingworth LLP 437,994$679,0000.19%
GREAT POINT PARTNERS LLC 250,000$395,0000.19%
Rhenman & Partners Asset Management AB 400,000$632,0000.18%
BVF INC/IL 559,624$884,0000.17%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,691,857$2,673,0000.10%
Perceptive Advisors 503,156$795,0000.07%
Gruss Capital Management LP 960,000$1,517,0000.04%
Spark Investment Management LLC 103,400$160,0000.03%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders